PRAGIOLA kõvakapsel Естонија - Естонски - Ravimiamet

pragiola kõvakapsel

first pharma oÜ - pregabaliin - kõvakapsel - 150mg 90tk; 150mg 100tk; 150mg 30tk; 150mg 28tk; 150mg 14tk; 150mg 56tk; 150mg 60tk; 150mg 84tk

TRESUVI infusioonilahus Естонија - Естонски - Ravimiamet

tresuvi infusioonilahus

orpha-devel handels und vertriebs gmbh - treprostiniil - infusioonilahus - 2,5mg 1ml 10ml 1tk

TRESUVI infusioonilahus Естонија - Естонски - Ravimiamet

tresuvi infusioonilahus

orpha-devel handels und vertriebs gmbh - treprostiniil - infusioonilahus - 10mg 1ml 10ml 1tk

TRESUVI infusioonilahus Естонија - Естонски - Ravimiamet

tresuvi infusioonilahus

orpha-devel handels und vertriebs gmbh - treprostiniil - infusioonilahus - 5mg 1ml 10ml 1tk

TRESUVI infusioonilahus Естонија - Естонски - Ravimiamet

tresuvi infusioonilahus

orpha-devel handels und vertriebs gmbh - treprostiniil - infusioonilahus - 1mg 1ml 10ml 1tk

Sogroya Европска Унија - Естонски - EMA (European Medicines Agency)

sogroya

novo nordisk a/s - somapacitan - kasv - hüpofüüsi ja hüpotaalamuse hormoonid ja analoogid - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children  aged 3  years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Efmody Европска Унија - Естонски - EMA (European Medicines Agency)

efmody

diurnal europe b.v. - hüdrokortisoon - adrenal hyperplasia, congenital - kortikosteroidid süsteemseks kasutamiseks - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Европска Унија - Естонски - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaktsiinid - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Roctavian Европска Унија - Естонски - EMA (European Medicines Agency)

roctavian

biomarin international limited - valoctocogene roxaparvovec - antihemorraagilised ained - treatment of severe haemophilia a (congenital factor viii deficiency) in adult patients without a history of factor viii inhibitors and without detectable antibodies to adeno-associated virus serotype 5 (aav5).

PRODUODOPA infusioonilahus Естонија - Естонски - Ravimiamet

produodopa infusioonilahus

abbvie sia - foslevodopa+foskarbidopa - infusioonilahus - 240mg+12mg 1ml 10ml 7tk